Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;476(4):1905-1913.
doi: 10.1007/s11010-020-04009-w. Epub 2021 Jan 25.

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis

Affiliations

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis

Zhengyao Song et al. Mol Cell Biochem. 2021 Apr.

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common male urological disease characterized by chronic pelvic pain. Extracorporeal shock wave therapy (ESWT) has been used to treat patients with CP/CPPS, but the parameters used by ESWT are not uniformly determined. Herein, this study aims to assess the effects of ESWT with different energy flux densities on pelvic pain in CP/CPPS rats and to explore the mechanisms. A rat model of CP/CPPS was induced by intraprostatic injection of 1% carrageenan. ESWT with different energy flux densities (0.09, 0.20, 0.30, 0.40 mJ/mm2) was applied in the pelvic region of CP/CPPS rats once a week for 4 weeks. The results showed that compared with the other energy flux densities (0.09, 0.30, and 0.40 mJ/mm2), ESWT with 0.20 mJ/mm2 exhibited a more powerful effect in alleviating pelvic pain and prostate damage. The therapeutic effect is associated with the reduction of the number of total and degranulated mast cells. Collectively, ESWT with 0.20 mJ/mm2 achieved the optimal therapeutic effect in alleviating pelvic pain in CP/CPPS rats.

Keywords: Chronic pelvic pain syndrome; Chronic prostatitis; Extracorporeal shock wave therapy; Mast cells.

PubMed Disclaimer

References

    1. Wang H-J, Tyagi P, Chen Y-M, Chancellor MB, Chuang Y-C (2019) Low energy shock wave therapy inhibits inflammatory molecules and suppresses prostatic pain and hypersensitivity in a capsaicin induced prostatitis model in rats. Int J Mol Sci 20:4777. https://doi.org/10.3390/ijms20194777 - DOI - PMC
    1. Jia J, Shen X, Wang L, Zhang T, Xu M, Fang X, Xu G, Qian C, Wu Y, Geng H (2013) Extracorporeal shock wave lithotripsy is effective in treating single melamine induced urolithiasis in infants and young children. J Urol 189:1498–1502. https://doi.org/10.1016/j.juro.2012.11.109 - DOI - PubMed
    1. Cao DZ, Wang CL, Qing Z, Liu LD (2019) Effectiveness of extracorporeal shock-wave therapy for frozen shoulder: a protocol for a systematic review of randomized controlled trial. Medicine (Baltimore) 98:e14506. https://doi.org/10.1097/md.0000000000014506 - DOI
    1. Guo P, Gao F, Zhao T, Sun W, Wang B, Li Z (2017) Positive effects of extracorporeal shock wave therapy on spasticity in poststroke patients: a meta-analysis. J Stroke Cerebrovasc Dis 26:2470–2476. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.08.019 - DOI - PubMed
    1. Wang CJ, Ko JY, Chou WY, Cheng JH, Kuo YR (2018) Extracorporeal shockwave therapy for treatment of keloid scars. Wound Repair Regen 26:69–76. https://doi.org/10.1111/wrr.12610 - DOI - PubMed

LinkOut - more resources